Nextech Invest, Ltd.
- SEC CIK
- 0001595430
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 17
- +1 vs. Q4 2025
- Portfolio value
- $1.42B
- +$386.6M (+37.4%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 7,601,087 | $739.2M | 52.0% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 4,055,861 | $155.3M | 10.9% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 7,266,081 | $152.0M | 10.7% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 7,162,637 | $90.8M | 6.4% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 3,540,998 | $78.0M | 5.5% | +625,000+21.4% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 5,526,506 | $55.0M | 3.9% | +825,000+17.5% | Added | History |
| ZYMEZymeworks Inc. | COM | 1,113,946 | $27.9M | 2.0% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 278,896 | $23.2M | 1.6% | 00.0% | Unchanged | History |
| CTMXCytomX Therapeutics, Inc. | COM | 4,449,932 | $20.9M | 1.5% | +4,449,932 | New | History |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $19.4M | 1.4% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,141,145 | $16.2M | 1.1% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 2,324,943 | $15.8M | 1.1% | +200,000+9.4% | Added | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 450,000 | $6.58M | 0.5% | +450,000 | New | History |
| ARVNArvinas, Inc. | COM | 539,394 | $5.72M | 0.4% | 00.0% | Unchanged | History |
| SLNSilence Therapeutics plc | ADS | 952,400 | $5.02M | 0.4% | 00.0% | Unchanged | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 304,237 | $5.00M | 0.4% | +25,000+9.0% | Added | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 610,703 | $4.90M | 0.3% | −50,000−7.6% | Reduced | History |
Sold out since Q4 2025 (1)
Positions held at the end of Q4 2025 that are gone from this filing.